Data / Form D filings / KIORA PHARMACEUTICALS INC
KIORA PHARMACEUTICALS INC: Form D filings
KIORA PHARMACEUTICALS INC, a pharmaceuticals company in Encinitas, CA, filed 17 Form D notices with the SEC between 2009 and 2026. The latest, on April 21, 2026, reports $5 million sold of a $5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 169 SAXONY RD. SUITE 212, Encinitas, CA, 92024
- Phone
- (858) 224-9600
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1372514
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | New notice | $5,000,000 | $5,000,000 | 3 | Apr 6, 2026 | sec.gov | |
| Feb 14, 2024 | New notice | $15,000,000 | $15,000,000 | 13 | Feb 5, 2024 | sec.gov | |
| Feb 17, 2023 | New notice | $200,000 | $200,000 | 1 | Feb 3, 2023 | sec.gov | |
| Feb 17, 2023 | New notice | $10,000,000 | $0 | $10,000,000 | 1 | Yet to occur | sec.gov |
| Nov 4, 2021 | New notice | Indefinite | $67,258 | 6 | Oct 21, 2021 | sec.gov | |
| Aug 23, 2021 | New notice | $10,750,013 | $10,750,013 | 14 | Aug 9, 2021 | sec.gov | |
| Jan 21, 2021 | New notice | $8,000,003 | $8,000,003 | 1 | Jan 6, 2021 | sec.gov | |
| Jan 4, 2021 | New notice | Indefinite | $3,203,083 | 15 | Dec 18, 2020 | sec.gov | |
| Jan 15, 2020 | New notice | Indefinite | $0 | 5 | Jan 3, 2020 | sec.gov | |
| Oct 8, 2019 | New notice | $1,875,000 | $1,875,000 | 1 | Oct 2, 2019 | sec.gov | |
| Jul 7, 2016 | New notice | $3,768,750 | $3,768,750 | 2 | Jun 30, 2016 | sec.gov | |
| Mar 21, 2016 | New notice | $2,618,797 | $2,618,797 | 32 | Mar 7, 2016 | sec.gov | |
| Jul 24, 2014 | New notice | $2,000,000 | $994,843 | $1,005,157 | 18 | Jun 6, 2014 | sec.gov |
| Sep 26, 2013 | New notice | $1,448,264 | $968,971 | $479,293 | 21 | Jul 29, 2013 | sec.gov |
| Jan 5, 2011 | New notice | $4,450,648 | $4,450,648 | 9 | Dec 30, 2010 | sec.gov | |
| Dec 21, 2009 | New notice | $22,641,695 | $11,081,232 | $11,560,463 | 20 | Dec 8, 2009 | sec.gov |
| Nov 13, 2009 | New notice | $490,000 | $490,000 | 4 | Oct 30, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Strem | Executive Officer | President and Chief Executive Officer |
| Melissa Tosca | Executive Officer | Chief Financial Officer |
| Carmine Stengone | Director | |
| Aron Shapiro | Director | |
| Lisa Walters-Hoffert | Director | |
| Praveen Tyle | Director | |
| David Hollander | Director | |
| Erin Parsons | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Apr 20, 2026 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what KIORA PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.